¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"air space disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • disease susceptibility
    Áúº´°¨¼ö¼º
  • disease taxonomy
    Áúº´ºÐ·ùÇÐ
  • extramammary Paget disease
    À¯¹æ¿ÜÆÄÁ¦Æ®º´
  • extrapyramidal disease
    ÇǶó¹Ìµå¹Ù±ù±æº´, Ãßü¿Ü·Îº´
  • endemic disease
    dzÅ亴, Áö¹æÀ¯Çິ
  • enzootic disease
    µ¿¹°Áö¹æº´, µ¿¹°ÅäÂøº´
  • epidemic disease
    À¯Çິ
  • Fabry disease
    ÆÄºê¸®º´
  • fat deficiency disease
    Áö¹æ°áÇ̺´
  • febrile disease
    ¿­º´
  • fibrocystic disease
    ¼¶À¯³¶º´
  • fifth disease
    Á¦5º´, °¨¿°È«¹Ý
  • Fahr disease
    ÆÄ¸£º´
  • fluke disease
    ÈíÃæº´
  • foot process disease
    ¹ßµ¹±âº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • cystine storage disease
    ½Ã½ºÆ¾ÃàÀûº´
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÆ÷ÇÔº´
  • disease control
    Áúº´°ü¸®
  • venereal disease control
    ¼ºº´°ü¸®
  • disease
    º´
  • deficiency disease
    ¿µ¾ç°áÇ̺´
  • degenerative disease
    ÅðÇິ
  • degenerative joint disease
    (¢¡osteoarthritis) »À°üÀý¿°, °ñ°üÀý¿°
  • demyelinating disease
    ¸»ÀÌÁýÅ»¶ôº´
  • dense deposit disease
    °í¹ÐµµÄ§Âøº´
  • depression spectrum disease
    ¿ì¿ï½ºÆåÆ®·³º´
  • detergent worker¡¯s disease
    ¼¼Á¤Á¦Ãë±ÞÀÚº´
  • developmental disease
    ¹ß´ÞÀå¾Ö
  • diarrheal disease
    ¼³»çº´
  • diffuse collagen disease
    ±¤¹üÀ§¾Æ±³Áúº´, ¹Ì¸¸¾Æ±³Áúº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • Hashimotos disease =H. thyroiditis
    ÇϽøðÅ亴.
  • Heerfordts disease=>uveoparotid fever
    Ç츣Æ÷¸£Æ®º´
  • Herlitz disease => generalized junctinal epidermolysis bullosa
    Àü½Å¼º °æ°è¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • Hers disease
    Ç㽺º´
  • Hirschsprung s disease
    Ç츣½¬½ºÇÁ·îº´.
  • Hirschsprungs disease
    È÷¸£½¬½ºÇÁ·îº´
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Huntingtons disease
    ÇãÆÃÅæ¹«µµº´
  • Huntingtons disease
    ÇåÆÃÅæ º´
  • Hyaline membrane disease
    À¯¸®Áú¸·º´(ë¤×ãòõدܻ)
  • Internation Classification of Disease(ICD)
    ±¹Á¦Áúº´ºÐ·ù.
  • Jacob-Creutzfeldt disease
    ¾ßÄß-Å©·çÃ÷ÆçÆ®º´
  • Johnes disease
    ÁÔÁúȯ
  • Kahler s disease
    Ä®·¯º´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • palmar space
    ¼öÀå°£°Ý(â¢íæÊà̰).
  • parapharyngeal space
    ÀεÎÁÖÀ§°­
  • parapharyngeal space
    ÀεÎÁÖÀ§°£±Ø.
  • paravertebral space
    ôÃßÁÖÀ§±Ø(¡­ÐÀ).
  • parotid space
    ÀÌÇϼ±°­
  • perichoroidal space
    ¸Æ¶ô¸·ÁÖÀ§°ø°£
  • perilymphatic space
    ¹Ù±ù¸²ÇÁ°ø°£
  • perineurial space
    ½Å°æÁÖÀ§°­(ãêÌèñ²êÌË·).
  • peripharyngeal space
    ÀεÎÁÖÀ§°ø°£
  • peripharyngeal space
    ÀεÎÁÖÀ§°ø°£(ìÖÔéñ²êÌÍöÊà).
  • peripharyngeal space
    ÀεÎÁÖÀ§°ø°£
  • peripheral interstitial space
    ¸»ÃÊ °£Áú °ø°£
  • periplasmic space
    ¿øÇüÁú¸· ÁÖÀ§°ø°£
  • perisinusoidal space
    µ¿¸ð¾çÇ÷°üÁÖÀ§°ø°£, µ¿¾çÇ÷°üÁÖÀ§°£°Ý(÷ÓåÆúìηñ²êÌÊà ̰).
  • perisinusoidal space
    µ¿±¼ÁÖÀ§°ø°£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
Vd/Vt dead space ventilation/total ventilation [ratio]
VPS ventriculoperitoneal shunt; verbal pain scale; virtual point source; visual pleural space; volume pe...
VRS verbal rating scale; Virchow-Robin space
AC   1) Adenylate Cyclase
  2) Abdominal Circumference
  3) Air Con...
AAP air at atmospheric pressure; American Academy of Pediatrics; American Academy of Pedodontics; Americ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
BDV Border Disease Virus
BD Borna Disease
BDV Borna Disease Virus
BRD Bovine Respiratory Disease
BVD-MD Bovine viral diarrhea-mucosal disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cyanotic heart disease
    û»ö¼º ½ÉÀå Áúȯ
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë¼º ºÀÀÔü º´, °Å´ë ¼¼Æ÷ ºÀÀÔü Áúȯ
  • cytomegaloviral disease
    °Å´ë ¼¼Æ÷ ¹ÙÀÌ·¯½º Áúȯ
  • Darier's disease
    ´ë¸®¾î º´
    µ¿ÀǾî=
  • degenerative brain disease
    ÅðÇ༺ ³ú Áúȯ
  • degenerative disease
    ÅðÇ༺ Áúȯ
  • degenerative joint disease
    ÅðÇ༺ °üÀý Áúȯ
    °üÀý ±¸Á¶¹°¿¡ ÀûÀÀ ÇѰ踦 ³Ñ¾î¼­´Â ÈûÀÌ °è¼Ó °¡ÇØÁö¸é °üÀý¸é, Ȱ¸·, °üÀý³¶¿¡ ¿°Áõ¼º º´º¯ÀÌ »ý±â´Â °æ¿ì.
  • demyelination disease
    Å»¼öÃÊ Áúȯ
    ½Å°æ¿¡ ¼öÃʰ¡ ¾ø¾î¼­ µµ¾à Àüµµ°¡ ÀϾÁö ¾Ê¾Æ ¾ß±âµÇ´Â Áúȯµé.
  • dercums disease
    ´õÄÄ º´
  • devics disease
    µ¥ºò º´
    µ¿ÀǾî=o
  • digestive tract disease
    ¼ÒÈ­±â °èÅë Áúȯ
  • disease
    º´, Áúº´, Áúȯ
    ÀÎÁö °¡´ÉÇÑ ÀÏ·ÃÀÇ Â¡ÈÄ¿Í Áõ»ó, ½Åü ¼Ò°ßÀÌ Æ¯Â¡ÀÎ Áúº´
  • disease entity
    Áúº´ ´ÜÀ§
  • disease of the esophagus
    ½Äµµ Áúȯ
  • disease of the lymphreticular system
    ¸²ÇÁ ¼¼¸Á³»ÇǰèÀÇ Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
Almeida's disease <microbiology> A chronic fungal infection caused by Paracoccidioides brasiliensis.
It is characterised by primary pulmonary lesions with dissemination to many visceral organs.
Common findings include ulcerative granuloma lesions to the buccal mucosa (inner lining of the cheek) and nasal mucosa that extend to the surrounding skin. Generalised lymphangitis is also typical.
More commonly seen in South America and the tropics.
(15 Nov 1997)
Alpers disease Familial progressive spastic paresis of extremities with progressive mental deterioration, with development of seizures, blindness and deafness, beginning during the first year of life, and with destruction and disorganization of nerve cells of the cerebral cortex.
Synonym: Alpers disease, Christensen-Krabbe disease, progressive cerebral poliodystrophy.
(05 Mar 2000)
alpha chain disease A vague or indefinite term; could be used for alpha-heavy-chain disease (a lymphoplasma cell proliferative disease usually seen in Mediterranean men, characterised by intestinal involvement with steatorrhoea, often progressive with fatal outcome) or a thalassaemia (a genetic abnormality in the alpha globin chain of haemoglobin).
(05 Mar 2000)
altitude disease A condition that results from prolonged exposure to high altitude.
Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse.
Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox).
(27 Sep 1997)
alzheimer disease A degenerative organic mental disease characterised by progressive brain deterioration and dementia. The disease was originally described as dementia, presenile occurring in persons under the age of 65 (as opposed to dementia, senile with onset at or after 65); however, onset may occur at any age. There is no pathophysiological nor clinical distinction between the two stages of onset of alzheimer's. Women appear to be affected twice as frequently as men. It is characterised pathologically by the triad of senile plaques, neurofibrillary tangles, and neuropil threads.
(12 Dec 1998)
Alzheimer's disease <disease> A progressive, neurodegenerative disease characterised by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
The cause of nerve cell death is unknown but the cells are recognised by the appearance of unusual helical protein filaments in the nerve cells (neurofibrillary tangles) and by degeneration in cortical regions of brain, especially frontal and temporal lobes.
Alzheimer's disease is the most common cause of dementia.
(22 May 1997)
anaemia of chronic disease <disease> A form of anaemia which develops as the result of a long-term infection or illness. Chronic diseases can interfere with red blood cell production in addition to shortening red blood cell life span in the body.
Symptoms are largely due to the underlying disease. Haemoglobin and haematocrit are generally low. Iron studies may be low to normal. Red blood cell indices may usually normal.
(27 Sep 1997)
anarthritic rheumatoid disease Rheumatoid disease without arthritis.
(05 Mar 2000)
Anders' disease <disease> A disease accompanied by painful localised fatty swellings and by various nerve lesions. It is usually seen in women and may cause death from pulmonary complications.
(12 Dec 1998)
Andersen's disease Familial cirrhosis of the liver with storage of abnormal glycogen; glycogenosis due to deficiency of 1,4-alpha-glucan branching enzyme, resulting in accumulation of abnormal glycogen with long inner and outer chains in liver, kidney, muscle, and other tissues.
Synonym: Andersen's disease.
(05 Mar 2000)
antibody deficiency disease <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
anti-glomerular basement membrane disease Glomerulonephritis, usually of a generalised proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-gbm antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary haemorrhage the condition is called goodpasture syndrome.
(12 Dec 1998)
aortoiliac occlusive disease Obstruction of the abdominal aorta and its main branches by atherosclerosis.
(05 Mar 2000)
apical interstitial lung disease <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs.
Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection.
(25 Jun 1999)
Aran-Duchenne disease A serious neurologic disease that results from the progressive degeneration of the motor neurons.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á